Published in Cancer Res on April 01, 1992
Genetic alterations and epithelial dysplasia in juvenile polyposis syndrome and sporadic juvenile polyps. Am J Pathol (1997) 1.15
Pathological and molecular progression of astrocytomas in a GFAP:12 V-Ha-Ras mouse astrocytoma model. Am J Pathol (2005) 1.15
Comparison of p53 gene mutation and protein overexpression in colorectal carcinomas. Br J Cancer (1994) 1.08
Different mechanisms underlie DNA instability in Huntington disease and colorectal cancer. Am J Hum Genet (1997) 1.07
Antibodies against p53 are associated with poor prognosis of colorectal cancer. Br J Cancer (1995) 1.07
Clinical and pathological significance of microsatellite instability in sporadic endometrial carcinoma. Am J Pathol (1996) 1.06
p53 expression in colorectal adenomas. Am J Pathol (1993) 1.04
Physical deletion of the p53 gene in bladder cancer. Detection by fluorescence in situ hybridization. Am J Pathol (1994) 1.00
Mutations of Ki-ras and p53 genes in colorectal cancer and their prognostic significance. Gut (1994) 0.98
Clinical and pathological associations with p53 tumour-suppressor gene mutations and expression of p21WAF1/Cip1 in colorectal carcinoma. Br J Cancer (1996) 0.97
Associations of Ki-ras proto-oncogene mutation and p53 gene overexpression in sporadic colorectal adenomas with demographic and clinicopathologic characteristics. Cancer Epidemiol Biomarkers Prev (2006) 0.94
What we could do now: molecular pathology of colorectal cancer. Mol Pathol (2001) 0.88
Gallbladder carcinoma: the role of p53 protein overexpression and Ki-67 antigen expression as prognostic markers. HPB (Oxford) (2004) 0.88
Family history of cancer, body weight, and p53 nuclear overexpression in Duke's C colorectal cancer. Br J Cancer (1995) 0.86
Co-mutation of p53, K-ras genes and accumulation of p53 protein and its correlation to clinicopathological features in rectal cancer. World J Gastroenterol (2004) 0.84
Genetic prognostic markers in colorectal cancer. Mol Pathol (1997) 0.79
Genes mediating programmed cell death: an immunohistochemical study of bcl-2, c-myc and p53 expression in colorectal neoplasia. Clin Mol Pathol (1996) 0.77
Altered p53 in microdissected, metachronous, premalignant and malignant oral lesions from the same patients. Clin Mol Pathol (1995) 0.76
Preclinical evidence of Alzheimer's disease in persons homozygous for the epsilon 4 allele for apolipoprotein E. N Engl J Med (1996) 10.60
APC mutations occur early during colorectal tumorigenesis. Nature (1992) 9.50
Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer. N Engl J Med (1999) 7.81
Estimation and tests of haplotype-environment interaction when linkage phase is ambiguous. Hum Hered (2003) 5.06
Hypermethylation of the hMLH1 promoter in colon cancer with microsatellite instability. Cancer Res (1998) 4.39
Increasing incidence of adenocarcinoma of the esophagus and esophagogastric junction. Gastroenterology (1993) 4.23
Evaluation of candidate genes in case-control studies: a statistical method to account for related subjects. Am J Hum Genet (2001) 4.09
Apolipoprotein E status as a predictor of the development of Alzheimer's disease in memory-impaired individuals. JAMA (1995) 3.84
Microsatellite instability and 8p allelic imbalance in stage B2 and C colorectal cancers. J Natl Cancer Inst (1999) 3.46
Efficacy of bilateral prophylactic mastectomy in BRCA1 and BRCA2 gene mutation carriers. J Natl Cancer Inst (2001) 3.37
Microsatellite instability in colorectal cancer: different mutator phenotypes and the principal involvement of hMLH1. Cancer Res (1998) 3.36
Mutations in AXIN2 cause colorectal cancer with defective mismatch repair by activating beta-catenin/TCF signalling. Nat Genet (2000) 3.33
Actin mutations in dilated cardiomyopathy, a heritable form of heart failure. Science (1998) 3.22
Length of uninterrupted CGG repeats determines instability in the FMR1 gene. Nat Genet (1994) 3.22
Incidence of reading disability in a population-based birth cohort, 1976-1982, Rochester, Minn. Mayo Clin Proc (2001) 3.18
Plasma cell labeling index and beta 2-microglobulin predict survival independent of thymidine kinase and C-reactive protein in multiple myeloma. Blood (1993) 2.98
BRAF screening as a low-cost effective strategy for simplifying HNPCC genetic testing. J Med Genet (2004) 2.75
The frequency of hereditary defective mismatch repair in a prospective series of unselected colorectal carcinomas. Am J Hum Genet (2001) 2.68
Prevalence of Helicobacter pylori in specific forms of gastritis. Further evidence supporting a pathogenic role for H. pylori in chronic nonspecific gastritis. Dig Dis Sci (1991) 2.67
A trial of three regimens for primary amyloidosis: colchicine alone, melphalan and prednisone, and melphalan, prednisone, and colchicine. N Engl J Med (1997) 2.66
Menetrier's disease: a form of hypertrophic gastropathy or gastritis? Gastroenterology (1993) 2.52
Hippocampal volumes in cognitively normal persons at genetic risk for Alzheimer's disease. Ann Neurol (1998) 2.48
Major histocompatibility complex class I-recognizing receptors are disease risk genes in rheumatoid arthritis. J Exp Med (2001) 2.41
Acute hepatitis E by a new isolate acquired in the United States. Mayo Clin Proc (1997) 2.36
Gastric adenocarcinoma and Helicobacter pylori infection. J Natl Cancer Inst (1991) 2.35
Smoking, alcohol, and coffee consumption preceding Parkinson's disease: a case-control study. Neurology (2000) 2.31
Chromosome abnormalities clustering and its implications for pathogenesis and prognosis in myeloma. Leukemia (2003) 2.28
Colorectal cancer screening by detection of altered human DNA in stool: feasibility of a multitarget assay panel. Gastroenterology (2000) 2.25
Studies on repression of the histidine operon. II. The role of the first enzyme in control of the histidine system. Proc Natl Acad Sci U S A (1969) 2.23
Barrett's esophagus, high-grade dysplasia, and early adenocarcinoma: a pathological study. Am J Gastroenterol (1997) 2.23
Adenocarcinoma of the esophagogastric junction and Barrett's esophagus. Gastroenterology (1995) 2.23
Improvement of cast nephropathy with plasma exchange depends on the diagnosis and on reduction of serum free light chains. Kidney Int (2008) 2.21
Anxiety disorders and depressive disorders preceding Parkinson's disease: a case-control study. Mov Disord (2000) 2.20
Potential influence of migration bias in birth cohort studies. Mayo Clin Proc (1998) 2.19
Repression of the histidine operon: effect of the first enzyme on the kinetics of repression. J Bacteriol (1969) 2.18
Case-control studies of genetic markers: power and sample size approximations for Armitage's test for trend. Hum Hered (2001) 2.14
The molecular epidemiology of p53 gene mutations in human breast cancer. Trends Genet (1997) 2.14
Flying in the face of resistance: antiviral-independent benefit of HIV protease inhibitors on T-cell survival. Clin Pharmacol Ther (2007) 2.08
Clinical and pathologic correlation of 84 mucinous cystic neoplasms of the pancreas: can one reliably differentiate benign from malignant (or premalignant) neoplasms? Ann Surg (2000) 2.05
Sensitivity, specificity, and predictability of biopsy interpretations in chronic hepatitis. Gastroenterology (1993) 2.03
Thalidomide as initial therapy for early-stage myeloma. Leukemia (2003) 2.02
Denaturing high performance liquid chromatography (DHPLC) used in the detection of germline and somatic mutations. Nucleic Acids Res (1998) 1.99
Increased risk for cancer in patients with the Peutz-Jeghers syndrome. Ann Intern Med (1998) 1.96
Controlled trial of megestrol acetate for the treatment of cancer anorexia and cachexia. J Natl Cancer Inst (1990) 1.92
Sequence analysis of the fragile X trinucleotide repeat: implications for the origin of the fragile X mutation. Hum Mol Genet (1994) 1.90
Pervasive occult gastrointestinal bleeding in an Alaska native population with prevalent iron deficiency. Role of Helicobacter pylori gastritis. JAMA (1997) 1.89
Immunoglobulin D multiple myeloma: presenting features, response to therapy, and survival in a series of 53 cases. J Clin Oncol (1994) 1.88
Hippocampal atrophy and apolipoprotein E genotype are independently associated with Alzheimer's disease. Ann Neurol (1998) 1.86
Epidemiology of celiac sprue: a community-based study. Am J Gastroenterol (1994) 1.85
Apolipoprotein E: risk factor for Alzheimer disease. Am J Hum Genet (1994) 1.83
Pulmonary alveolar phospholipoproteinosis: experience with 34 cases and a review. Mayo Clin Proc (1987) 1.78
Pomalidomide (CC4047) plus low dose dexamethasone (Pom/dex) is active and well tolerated in lenalidomide refractory multiple myeloma (MM). Leukemia (2010) 1.77
Identification of an association between HLA class II alleles and low antibody levels after measles immunization. Vaccine (2001) 1.77
Microsatellite instability and mutation analysis of hMSH2 and hMLH1 in patients with sporadic, familial and hereditary colorectal cancer. Hum Mol Genet (1996) 1.76
Casein kinase II phosphorylates I kappa B alpha at S-283, S-289, S-293, and T-291 and is required for its degradation. Mol Cell Biol (1996) 1.72
Analysis of a CGG sequence at the FMR-1 locus in fragile X families and in the general population. Am J Hum Genet (1993) 1.71
Evidence for a prostate cancer-susceptibility locus on chromosome 20. Am J Hum Genet (2000) 1.69
Familial aneurysmal subarachnoid hemorrhage: a community-based study. J Neurosurg (1995) 1.68
High functioning fragile X males: demonstration of an unmethylated fully expanded FMR-1 mutation associated with protein expression. Am J Med Genet (1994) 1.68
Germ-line origins of mutation in families with hemophilia B: the sex ratio varies with the type of mutation. Am J Hum Genet (1993) 1.66
A practical guide to defining high-risk myeloma for clinical trials, patient counseling and choice of therapy. Leukemia (2007) 1.66
Peripheral blood monoclonal plasma cells as a predictor of survival in patients with multiple myeloma. Blood (1996) 1.65
Validation of a telephone questionnaire for Parkinson's disease. J Clin Epidemiol (1998) 1.65
Interaction between histidyl transfer ribonucleic acid and the first enzyme for histidine biosynthesis of Salmonella typhimurium. J Bacteriol (1970) 1.64
Cystic fibrosis and the phenotypic expression of autosomal dominant polycystic kidney disease. Am J Kidney Dis (1998) 1.64
Efficacy of contralateral prophylactic mastectomy in women with a personal and family history of breast cancer. J Clin Oncol (2001) 1.63
Evidence for autosomal dominant inheritance of prostate cancer. Am J Hum Genet (1998) 1.63
Serodiagnosis of Helicobacter pylori: comparison of enzyme-linked immunosorbent assays. J Clin Microbiol (1991) 1.59
Erythroid cell development in fetal mice: ultrastructural characteristics and hemoglobin synthesis. J Mol Biol (1967) 1.57
Regulation of histidine biosynthesis in Salmonella typhimurium. Curr Top Cell Regul (1972) 1.55
Autoimmune cholangitis within the spectrum of autoimmune liver disease. Hepatology (2000) 1.55
Impact of primary molecular cytogenetic abnormalities and risk of progression in smoldering multiple myeloma. Leukemia (2013) 1.54
Barrett's esophagus with high-grade dysplasia: an indication for esophagectomy? Ann Thorac Surg (1992) 1.54
A phase I study of 153Sm-EDTMP with fixed high-dose melphalan as a peripheral blood stem cell conditioning regimen in patients with multiple myeloma. Leukemia (2005) 1.51
The location of the Philadelphia chromosomal breakpoint site and prognosis in chronic granulocytic leukemia. Leukemia (1990) 1.49
Early gastric cancer. Br J Surg (1992) 1.49
Familial aggregation of gastroesophageal reflux in patients with Barrett's esophagus and esophageal adenocarcinoma. Gastroenterology (1997) 1.46
Iron overload in cirrhosis-HFE genotypes and outcome after liver transplantation. Hepatology (2000) 1.45
Hereditary motor and sensory neuropathy type 2C is genetically distinct from types 2B and 2D. Arch Neurol (2000) 1.45
Clinical spectrum of clonal proliferations of T-large granular lymphocytes: a T-cell clonopathy of undetermined significance? Blood (1994) 1.45
Eligibility for hematopoietic stem-cell transplantation for primary systemic amyloidosis is a favorable prognostic factor for survival. J Clin Oncol (2001) 1.45
Genotype prediction in the fragile X syndrome. J Med Genet (1991) 1.45
Host- and disease-specific factors affecting steatosis in chronic hepatitis C. J Hepatol (1998) 1.43
Rapid, nonradioactive screening for mutations in exons 10, 11, and 16 of the RET protooncogene associated with inherited medullary thyroid carcinoma. Clin Chem (1997) 1.42
Validity of family history data on PD: evidence for a family information bias. Neurology (2003) 1.41
Interaction between the first enzyme for histidine biosynthesis and histidyl transfer ribonucleic acid. J Bacteriol (1971) 1.41
Long-term satisfaction and psychological and social function following bilateral prophylactic mastectomy. JAMA (2000) 1.40
Radiation therapy for squamous cell carcinoma of the tonsil. Mayo Clin Proc (1994) 1.39
Searching for clues to effective use of biologic response modifiers. J Natl Cancer Inst (1991) 1.39
Genetic mapping of new DNA probes at Xq27 defines a strategy for DNA studies in the fragile X syndrome. Am J Hum Genet (1991) 1.38